About the Cancer Gene Therapy Session
Cancer gene therapy, a promising frontier in oncology, targets the genetic abnormalities underlying cancer. This approach involves introducing genetic material into cancerous cells to inhibit their growth or trigger cell death. One strategy employs viral vectors to deliver therapeutic genes selectively to tumor cells, while sparing healthy tissue. Another method utilizes gene editing tools like CRISPR to precisely alter cancer-related genes, correcting mutations or deactivating oncogenes. While still in its infancy, gene therapy holds immense potential for personalized cancer treatment, offering hope for more effective and targeted therapies with fewer side effects. However, challenges such as off-target effects and immune responses remain hurdles to overcome in realizing the full potential of this innovative approach.
Topics Covered in Cancer Gene Therapy
Viral Vectors
Oncolytic Viruses
CRISPR Gene Editing
Suicide Gene Strategies
Tumor Suppressor Restoration
Non-Viral Delivery
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Gene Therapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Gene Therapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Gene Therapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Gene Therapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Gene Therapy Conference 2027 — FAQs
What is the Cancer Gene Therapy track at CIOC 2027?
The Cancer Gene Therapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Gene Therapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Gene Therapy sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Gene Therapy are all welcome — whether presenting or attending.
Can I present my research in the Cancer Gene Therapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Gene Therapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Gene Therapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.